Evidence map›Paper›PMID 28699554›Full record

Trial reportBMC public health2017

Coverage and beliefs about temephos application for control of dengue vectors and impact of a community-based prevention intervention: secondary analysis from the Camino Verde trial in Mexico.

José Legorreta-Soberanis, Sergio Paredes-Solís, Arcadio Morales-Pérez, Elizabeth Nava-Aguilera, Felipé René Serrano de Los Santos, Belén Madeline Sánchez-Gervacio, Robert J Ledogar, Anne Cockcroft, Neil Andersson

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Efficacy of householdHeliyon · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

José Legorreta-SoberanisCentro de Investigación de Enfermedades Tropicales de la Universidad Autónoma de Guerrero, Acapulco, Guerrero, Mexico. jlegorreta@ciet.org.
Sergio Paredes-SolísCentro de Investigación de Enfermedades Tropicales de la Universidad Autónoma de Guerrero, Acapulco, Guerrero, Mexico.
Arcadio Morales-PérezCentro de Investigación de Enfermedades Tropicales de la Universidad Autónoma de Guerrero, Acapulco, Guerrero, Mexico.
Elizabeth Nava-AguileraCentro de Investigación de Enfermedades Tropicales de la Universidad Autónoma de Guerrero, Acapulco, Guerrero, Mexico.
Felipé René Serrano de Los SantosCentro de Investigación de Enfermedades Tropicales de la Universidad Autónoma de Guerrero, Acapulco, Guerrero, Mexico.
Belén Madeline Sánchez-GervacioCentro de Investigación de Enfermedades Tropicales de la Universidad Autónoma de Guerrero, Acapulco, Guerrero, Mexico.
Robert J LedogarCIETinternational, New York, NY, USA.
Anne CockcroftDepartment of Family Medicine, McGill University, Montreal, Canada.
Neil AnderssonCentro de Investigación de Enfermedades Tropicales de la Universidad Autónoma de Guerrero, Acapulco, Guerrero, Mexico.
Universidad Autónoma de Guerrero · MXMcGill University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTemephos in domestic water containers remains a mainstay of Latin American government programmes for control of Aedes aegypti and associated illnesses, including dengue. There is little published evidence about coverage of routine temephos programmes. A cluster randomised controlled trial of community mobilisation in Mexico and Nicaragua reduced vector indices, dengue infection, and clinical dengue cases. Secondary analysis from the Mexican arm of the trial examined temephos coverage and beliefs, and the impact of the trial on these outcomes.

methodsThe trial impact survey in December 2012, in 10,491 households in 45 intervention and 45 control clusters, asked about visits from the temephos programme, retention of applied temephos, and views about temephos and mosquito control. Fieldworkers noted if temephos was present in water containers.

resultsSome 42.4% of rural and 20.7% of urban households reported no temephos programme visits within the last 12 months. Overall, 42.0% reported they had temephos placed in their water containers less than 3 months previously. Fieldworkers observed temephos in at least one container in 21.1% of households. Recent temephos application and observed temephos were both significantly more common in urban households, when other household variables were taken into account; in rural areas, smaller households were more likely to have temephos present. Most households (74.4%) did not think bathing with water containing temephos carried any health risk. Half (51%) believed drinking or cooking with such water could be harmful and 17.6% were unsure. Significantly fewer households in intervention sites (16.5%) than in control sites (26.0%) (Risk Difference - 0.095, 95% confidence interval - 0.182 to -0.009) had temephos observed in their water; more households in intervention clusters (41.8%) than in control clusters (31.6%) removed the applied temephos quickly. Although fewer households in intervention sites (82.7%) compared with control sites (86.7%) (RD -0.04, 95% CI -0.067 to -0.013) agreed temephos and fumigation was the best way to avoid mosquitoes, the proportion believing this remained very high.

conclusionCoverage with the government temephos programme was low, especially in rural areas. Despite an intervention encouraging non-chemical mosquito control, most households continued to believe that chemicals are the best control method.

trial registrationISRCTN: 27581154 .

Indexed as

Health Knowledge, Attitudes, PracticeInsecticidesTemefosWater SupplyAedesAnimalsChildChild, PreschoolDengueFamily CharacteristicsFemaleFumigationHumansInsect VectorsMaleMexicoInsecticidesTemefosWaterAedes aegyptiCluster randomised controlled trialDengueTemephosVector control

Identifiers

PMID28699554
PMCPMC5506576
OpenAlexW2617998401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.